AstraZeneca partners up with CRUK for new UK cancer drug discovery facility

AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery and development of new cancer drugs, leveraging genetic screening, cancer modelling, big data processes and tools such as CRISPR to better understand tumour disease and resistance mechanisms and inform more effective drug targeting.

Located in the Milner Therapeutics Institute at the University of Cambridge, the Functional Genomics Centre, as the new facilities will be known, will seek to further investigate the relationship and function of tumour genes and proteins,

read more

More From BioPortfolio on "AstraZeneca partners up with CRUK for new UK cancer drug discovery facility"